These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
404 related items for PubMed ID: 15282218
1. Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats. Sakuma H, Kohyama K, Park IK, Miyakoshi A, Tanuma N, Matsumoto Y. Brain; 2004 Oct; 127(Pt 10):2201-13. PubMed ID: 15282218 [Abstract] [Full Text] [Related]
2. Characterization of the encephalitogenic immune response in a model of multiple sclerosis. de Graaf KL, Barth S, Herrmann MM, Storch MK, Wiesmüller KH, Weissert R. Eur J Immunol; 2008 Jan; 38(1):299-308. PubMed ID: 18050272 [Abstract] [Full Text] [Related]
3. Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor. Sasaki M, Lankford KL, Brown RJ, Ruddle NH, Kocsis JD. Glia; 2010 Oct; 58(13):1523-31. PubMed ID: 20645414 [Abstract] [Full Text] [Related]
4. Disparate MHC class II haplotypes in myelin oligodendrocyte glycoprotein- and myelin basic protein-induced experimental autoimmune encephalomyelitis. Muhallab S, Dahlman I, Wallström E. J Neuroimmunol; 2005 Apr; 161(1-2):155-61. PubMed ID: 15748954 [Abstract] [Full Text] [Related]
5. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice. Zhang GX, Yu S, Gran B, Li J, Calida D, Ventura E, Chen X, Rostami A. J Neuroimmunol; 2004 Mar; 148(1-2):1-10. PubMed ID: 14975581 [Abstract] [Full Text] [Related]
7. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis. Meeson AP, Piddlesden S, Morgan BP, Reynolds R. Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334 [Abstract] [Full Text] [Related]
8. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. Stefferl A, Brehm U, Storch M, Lambracht-Washington D, Bourquin C, Wonigeit K, Lassmann H, Linington C. J Immunol; 1999 Jul 01; 163(1):40-9. PubMed ID: 10384097 [Abstract] [Full Text] [Related]
9. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. Ichikawa M, Johns TG, Liu J, Bernard CC. J Immunol; 1996 Jul 15; 157(2):919-26. PubMed ID: 8752946 [Abstract] [Full Text] [Related]
10. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets. Jagessar SA, Smith PA, Blezer E, Delarasse C, Pham-Dinh D, Laman JD, Bauer J, Amor S, 't Hart B. J Neuropathol Exp Neurol; 2008 Apr 15; 67(4):326-40. PubMed ID: 18379435 [Abstract] [Full Text] [Related]
11. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Kerlero de Rosbo N, Mendel I, Ben-Nun A. Eur J Immunol; 1995 Apr 15; 25(4):985-93. PubMed ID: 7737302 [Abstract] [Full Text] [Related]
12. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide. Leadbetter EA, Bourque CR, Devaux B, Olson CD, Sunshine GH, Hirani S, Wallner BP, Smilek DE, Happ MP. J Immunol; 1998 Jul 01; 161(1):504-12. PubMed ID: 9647262 [Abstract] [Full Text] [Related]
13. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate. Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R. J Autoimmun; 2011 Nov 01; 37(3):228-41. PubMed ID: 21752599 [Abstract] [Full Text] [Related]
14. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. Johns TG, Kerlero de Rosbo N, Menon KK, Abo S, Gonzales MF, Bernard CC. J Immunol; 1995 May 15; 154(10):5536-41. PubMed ID: 7537310 [Abstract] [Full Text] [Related]
15. Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation. Tsunoda I, Kuang LQ, Igenge IZ, Fujinami RS. J Neuroimmunol; 2005 Mar 15; 160(1-2):122-34. PubMed ID: 15710465 [Abstract] [Full Text] [Related]
16. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat. Papadopoulos D, Pham-Dinh D, Reynolds R. Exp Neurol; 2006 Feb 15; 197(2):373-85. PubMed ID: 16337942 [Abstract] [Full Text] [Related]
17. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Merkler D, Ernsting T, Kerschensteiner M, Brück W, Stadelmann C. Brain; 2006 Aug 15; 129(Pt 8):1972-83. PubMed ID: 16714315 [Abstract] [Full Text] [Related]
18. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice. Berard JL, Wolak K, Fournier S, David S. Glia; 2010 Mar 15; 58(4):434-45. PubMed ID: 19780195 [Abstract] [Full Text] [Related]
19. MHC haplotype-dependent regulation of MOG-induced EAE in rats. Weissert R, Wallström E, Storch MK, Stefferl A, Lorentzen J, Lassmann H, Linington C, Olsson T. J Clin Invest; 1998 Sep 15; 102(6):1265-73. PubMed ID: 9739061 [Abstract] [Full Text] [Related]
20. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Lyons JA, Ramsbottom MJ, Cross AH. Eur J Immunol; 2002 Jul 15; 32(7):1905-13. PubMed ID: 12115610 [Abstract] [Full Text] [Related] Page: [Next] [New Search]